COVID-19 and financial toxicity in patients with renal cell carcinoma

• by Michael D. Staehler, Dena J. Battle, Cristiane D. Bergerot, Sumanta Kumar Pal, David F. Penson

• October 22, 2020

Molecular Profiling, Prognostic Insights, and Immune Landscape Evaluation of NUDT16 in Clear Cell Renal Cell Carcinoma

• by Chen Chen, Zhuojing Hu, Wei Zhao, Yunbo Ma, Qinghua Xia

• November 21, 2025

Kidney Cancer Updates - GU Oncology Cancer Highlights: ESMO 2024

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the kidney cancer clinical updates you need to know from ESMO 2024.

• November 4, 2024

• 1 min

Comprehensive analysis of fatty acid desaturase 3 in clear cell renal cell carcinoma: insights into tumor progression, immune microenvironment, and clinical outcomes

• by Si-Tao Chen, Duan-Rui Zhou, Yun-Jun Ge, Lei Chang, Shu-Hui Guo, Guo-Sheng Wu, Ning-Han Feng

• May 14, 2026